Navigation Links
Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis
Date:1/13/2009

- Merck Serono and Apitope to Collaborate on Development and Commercialization of ATX-MS-1467, Apitope's Peptide Therapeutic for the Treatment of Multiple Sclerosis (MS)

GENEVA, Jan. 13 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the signature of a research, development and commercialization agreement with Apitope Technology (Bristol) Ltd., a wholly owned subsidiary of Apitope International NV. Under this agreement, Apitope has granted exclusive worldwide rights to Merck Serono to develop and commercialize Apitope's product ATX-MS-1467. This peptide therapeutic has completed an initial clinical study in patients with multiple sclerosis (MS). It is designed to induce immunological tolerance of the body's T-cells to key autoantigens involved in the pathogenesis of MS.

ATX-MS-1467 is a novel peptide-based therapeutic derived from Apitope's proprietary technology platform. Under the terms of the agreement, Apitope will receive an upfront payment and will initially be responsible for the further development of ATX-MS-1467, for which Merck Serono will fund the costs. Merck Serono will be responsible for all development activities from the beginning of Phase II clinical trials. Merck Serono will also provide committed funding to Apitope for research on other novel therapeutic peptides for the treatment of MS.

Under the terms of the agreement, Apitope is eligible to receive up to EUR 154 million in upfront, development and commercialization milestone payments, in addition to royalties on the net sales of products resulting from the collaboration.

"This partnership with Apitope strengthens our position as a leader in the field of innovative research and development in multiple sclerosis," said Bernhard Kirschbaum, Executive Vice President Research and Development at Merck Serono. "ATX-MS-1467 represents a novel, targeted approach and may have the potenti
'/>"/>

SOURCE Merck Serono
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla
2. ARVO Foundation and Merck to provide prestigious global ophthalmic research award
3. Prasco to Distribute Generic Forms of Dorzolamide Hydrochloride-Timolol Maleate and Dorzolamide Hydrochloride Ophthalmic Solutions (Comparable to Mercks COSOPT(R) and TRUSOPT(R) Ophthalmic Solutions)
4. Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance
5. Mercks odanacatib increased BMD over 2 years at key fracture sites in Phase IIB study
6. Covance Recognized for Outstanding Performance by Merck & Co., Inc.
7. Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
8. Schiffrin Barroway Topaz & Kessler, LLP Announces Court Ruling Relating to Merck & Co. Inc.s Employee Savings & Security Plan, the Merck & Co., Inc. Employee Stock Purchase & Savings Plan, and the Merck Puerto Rico Employee Savings & Security Plan
9. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
10. Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck
11. UNICEF & Merck Partner to Protect 100,000 Children and Young People Against Mumps Epidemic

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...eneral Dentistry (AGD) announces that Aria Irvani,... Award during the AGD,s commencement celebration t...ce in dental education.,To accomplish this, Dr. I... dental education in the 16 disciplines of dentist...ls and techniques. , (PRW...
(Date:11/29/2009)...t equals a $41,000 pay raise, researchers say , ...ychological therapy may be much more effective at ...g a lottery prize, suggests an English study. ,...who provided information about their mental well-b... a $1,329 course of therapy was so significant tha...
(Date:11/28/2009).../ -- Get ready for advanced visualization to be...hen Siemens introduces syngo. via(1) at the...e Radiological Society of North America (RSNA) fro...oth #825, East Building/Lakeside Center, Hall D) i...imaging software for multimodality reading of clin...
(Date:11/27/2009)...e/ - Uploadable USB pedometers may be new, but the...ination of advanced accelerometer functionality an...ncern over the accuracy of self-reported data. It,...oved participation in a fitness program. ,, Cor...suppliers to integrate this technology. "Our healt...
(Date:11/27/2009)...ov. 27 Team Garmin-Slipstream, the...d to ethical sporting and developing the next gene...it will become Team Garmin-Transitions with the ad...the team. Transitions Optical is the world,s leadi...most advanced photochromic technology in the wides...
Breaking Medicine News(10 mins):Health News:Orange County Dentist Honored by The Academy of General Dentistry 2Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3
... Replay Instructions Below, SAN DIEGO, May 8 Max...uct its Annual Meeting of Stockholders today at th...r Drive., For those who are unable to attend, the...,archived and available for subsequent Internet re...
...8, 2008 Wouldnt it be nice if our doctors could p...rticular medication" This question is important b...how groups of patients tend to respond to treatmen...als from those groups. Personalized medicine is t...
...as provided, for the first time, a detailed map of...lar structures that contain genes, are organized i... identifies a critical stop sign for transcription... the 15 May 2008 issue of the journal Nature. , T...
...Nile Therapeutics,Inc. (OTC Bulletin Board: NILT.O...ing therapies for cardiovascular disease, is pleas...D., LL.M. as its Vice President of,Regulatory Affa...egulatory affairs background will be of great valu...
...ress begins hearings on pharmaceuticals in water, ...lieve federal laws governing drinking water are no... poll conducted for the Water,Quality Association.... water. The U.S. Senate has begun public hearings,...
...O & Thousands of Philadelphians are expected to j... afternoon filled with live entertainment,... to raise awareness about lupus. Live music...rge to everyone., WHY: Although first r...
Other Medicine News:Health News:Improving anxiety treatment through the help of brain imaging: A potential future treatment strategy 2Health News:Scientists identify key roadblock to gene expression 2Health News:Jane Moffitt, J.D., LL.M. Named Vice President of Regulatory Affairs of Nile Therapeutics 2Health News:Jane Moffitt, J.D., LL.M. Named Vice President of Regulatory Affairs of Nile Therapeutics 3Health News:Half of Americans Want Stricter Water Quality Laws, Survey Finds 2Health News:5th Annual World Lupus Day Philadelphians Take Part In a Global Rally of Support 2
(Date:11/29/2009)...CAGO, Nov. 29 FUJIFILM Medical Sys...ital Mammography (FFDM) with over 7,000 installati...m for the first time in the US. The Aspire HD com...enium (a-Se) next generation detector technology a...and higher spatial resolution at a reduced dose fo...
(Date:11/29/2009)...O, Nov. 29 Researchers using funct...rain activation have found that men and women resp...according to a study presented today at the annual...ica (RSNA). ,, "Men may direct more attention t... process them in terms of implications for require...
(Date:11/27/2009)...T LAKE CITY, Nov. 27 Boo...nc. (NYSE: VAR ), a premier supplier of X-ray tu...xhibit its full range of detectors at the RSNA Ann...cember 3, 2009. Varian will also be exhibiting X-...l as specialized cancer treatment technologies. ,...
Breaking Medicine Technology:FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 2FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 3FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 4New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2New Collaborations and Breakthrough Advancements in RNA Based Drug Development Programs Lead Santaris Pharma A S to Establish US Operations 14077 1New Collaborations and Breakthrough Advancements in RNA Based Drug Development Programs Lead Santaris Pharma A S to Establish US Operations 14077 2New Collaborations and Breakthrough Advancements in RNA Based Drug Development Programs Lead Santaris Pharma A S to Establish US Operations 14077 3New Collaborations and Breakthrough Advancements in RNA Based Drug Development Programs Lead Santaris Pharma A S to Establish US Operations 14077 4CEL SCI to Commence First Clinical Study with Hospitalized H1N1 Infected Patients 14075 1CEL SCI to Commence First Clinical Study with Hospitalized H1N1 Infected Patients 14075 2CEL SCI to Commence First Clinical Study with Hospitalized H1N1 Infected Patients 14075 3CEL SCI to Commence First Clinical Study with Hospitalized H1N1 Infected Patients 14075 4Los Angeles Dentist Dr Sam Muslin Receives LAs Best Award 2009 57313 1Los Angeles Dentist Dr Sam Muslin Receives LAs Best Award 2009 57313 2Los Angeles Dentist Dr Sam Muslin Receives LAs Best Award 2009 57313 3Los Angeles Dentist Dr Sam Muslin Receives LAs Best Award 2009 57313 4Los Angeles Dentist Dr Sam Muslin Receives LAs Best Award 2009 57313 5Los Angeles Dentist Dr Sam Muslin Receives LAs Best Award 2009 57313 6Los Angeles Dentist Dr Sam Muslin Receives LAs Best Award 2009 57313 7
Platelet Incubator 3612
Platelet Incubator TPSRI-16
ImmuLisa™ anti-gliadin-IgG Kit
AUTION MAX AX-4280 Automated Urine Chemistry Analyzer
Medicine Products: